Celerion Expands Early Phase Clinical Operations Units
Biopharmaceutical clinical research organization, Celerion, has this year announced a considerable expansion that involves adding extensive research capacity and services. The company is adding significantly to the resources that it has for early phase clinical research, including upgrading pharmacy compounding suites and opening a new Screening and Return Center. This new capacity comes in the form of development at existing sites, including a new 40,000 square foot facility in Phoenix, Arizona that will add 350 beds to the company's capacity....
View full press release